PSA-DETECTED (CLINICAL STAGE T1c OR B0) PROSTATE CANCER
- 1 November 1993
- journal article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 20 (4) , 687-693
- https://doi.org/10.1016/s0094-0143(21)00921-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Large, Organ Confined, Impalpable Transition Zone Prostate Cancer: Association with Metastatic Levels of Prostate Specific AntigenJournal of Urology, 1993
- Clinical stage Bo or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentrationUrology, 1993
- Serum Prostate Specific Antigen as Pre-Screening Test for Prostate CancerJournal of Urology, 1992
- Screening for Prostatic Carcinoma with Prostate Specific AntigenJournal of Urology, 1992
- The TNM classification of prostate cancerThe Prostate, 1992
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific AntigenJournal of Urology, 1990
- Random Systematic Versus Directed Ultrasound Guided Transrectal Core Biopsies of the ProstateJournal of Urology, 1989
- Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.Journal of Histochemistry & Cytochemistry, 1983